Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Chromosome 1q Amplification Is Associated with a History of Prior Malignancies Among Patients Newly Diagnosed with Multiple Myeloma

Elizabeth B Lamont, MD MS, MMSc, Andrew J. Yee, MD, Stuart L. Goldberg, MD, Andrew D Norden, MD MPH, MBA

Blood (2019) 134 (Supplement_1): 2193.

https://doi.org/10.1182/blood-2019-125407

Published: 2019

Journal Articles

A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation

Blood (2019) 134 (Supplement_1): 4153.

https://doi.org/10.1182/blood-2019-129335

Published: 2019

Journal Articles

Molecular Mechanisms of Primary Resistance to Azacitidine in MDS/AML Patients - Data of the Hellenic MDS Study Group

Vassiliki Mpakou, PhD, Aris Spathis, PhD, Anthi Bouhla, MD, Frieda Kontsioti, PhD, Zoi Tsakiraki, MD, Sotirios Papageorgiou, MD PhD, Efthimia Mpazani, MD, Irene Glezou, MD, Konstantinos Gkodopoulos, MD, Georgia Stavroulaki, MD, Athanasios Galanopoulos, MD PhD, Argiris Symeonidis, MD PhD, Nora-Athina Viniou, MD PhD, Kalliopi Zafeiropoulou, Ioannis Kotsianidis, MD PhD, Periklis Foukas, MD PhD, Vassiliki Pappa, MD

Blood (2019) 134 (Supplement_1): 5403.

https://doi.org/10.1182/blood-2019-122424

Published: 2019

Journal Articles

Neurodevelopmental Disorders in Pediatric Sickle Cell Disease

Eboni I. Lance, MD, Alicia D. Cannon, PhD, Bruce K. Shapiro, MD, Michael V. Johnston, MD, James F. Casella, MD

Blood (2019) 134 (Supplement_1): 1016.

https://doi.org/10.1182/blood-2019-121968

Published: 2019

Journal Articles

Interest of a New Method for Free Plasma Heme Related Species Dosages in Sickle Cell Disease and Beta Thalassemia

Laurent Kiger, Sandia Adypagavane, Laura Bencheikh, PhD, Nicolas Hebert, Stephane Moutereau, MD, Frédéric Galactéros, MD PhD, Michael Marden, PhD, Yves Beuzard, MD, France Pirenne, MD PhD, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 3381.

https://doi.org/10.1182/blood-2019-130600

Published: 2019

Journal Articles

Characterization of Soluble Immune Checkpoint Protein PD-1, PD-L1 and PD-L2 Levels in Different Types of Lymphoid Malignancies

Julie Bondgaard Mortensen, MS, Vladimirova Yoanna, B.Sc, Ida Monrad Hansen, B.Sc., Mette Bjerre, M.Sc. PhD, Francesco d'Amore, MD

Blood (2018) 132 (Supplement 1): 5306.

https://doi.org/10.1182/blood-2018-99-114509

Published: 2018

Journal Articles

HMGB1 As a Novel Platelet Agonist That Acts Synergistically with ADP to Activate Platelets in Sickle Cell Disease

Deirdre Nolfi-Donegan, MD, Sruti Shiva, PhD, Cheryl A Hillery, MD

Blood (2018) 132 (Supplement 1): 1073.

https://doi.org/10.1182/blood-2018-99-110269

Published: 2018

Journal Articles

Impact of AML on Patients' Lives: The Value of HM-PRO Measurements

Esther Natalie Oliva, MD, Sam Salek, PhDRPh FFPM MCMS MRPSGB FESCP, Pushpendra Goswami, PhD MSc, BPharm, Tatyana Ionova, PhD

Blood (2018) 132 (Supplement 1): 5900.

https://doi.org/10.1182/blood-2018-99-117600

Published: 2018

Journal Articles

Utility of Repeat Testing in the Evaluation for Von Willebrand Disease in Pediatric Patients

Bhavya S Doshi, MD, Rachel S Rogers, MS, Hilary B Whitworth, MD, Emily Stabnick, BA, Jessica Britton, BA, Regina Butler, RN-BC, Char M Witmer, MDMSCE

Blood (2018) 132 (Supplement 1): 981.

https://doi.org/10.1182/blood-2018-99-115607

Published: 2018

Journal Articles

Cardiorenal Syndrome in Thalassemia Patients

Sorasak Makmettakul, MD, Adisak Tantiworawit, MD, Suree Lekawanvijit, MD, Arintaya Phrommintikul, MD, Thanawat Rattanathammethee, MD, Sasinee Hantrakool, MD, Chatree Chai-Adisaksopha, MD, Ekarat Rattarittamrong, MD, Lalita Norasetthada, MD

Blood (2017) 130 (Supplement 1): 3507.

https://doi.org/10.1182/blood.V130.Suppl_1.3507.3507

Published: 2017

Journal Articles

Cytokine Release from Stimulated PBMC after-HSCT: Results of a Post-Transplant Zinc Oral Supplementation Trial (ZENITH)

Lorenzo Iovino, MD, Federico Pratesi, BD, Francesco Mazziotta, MD, Enrico Orciuolo, PhD MD, Gabriele Buda, PhD MD, Edoardo Benedetti, MD, Mario Petrini, PhD MD Prof, Paola Migliorini, PhD MD Prof, Sara Galimberti, PhD MD

Blood (2017) 130 (Supplement 1): 1017.

https://doi.org/10.1182/blood.V130.Suppl_1.1017.1017

Published: 2017

Journal Articles

Counseling Patients (pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS) Regarding Expected Survival with Azacitidine (aza) Therapy: Are We Using Accurate Estimates?

Michelle Deveaux, Maximilian Stahl, MD, Smith Giri, MBBS, Rong Wang, PhD, Nikolai A. Podoltsev, MD PhD, Xiaomei Ma, MD PhD, Amer M. Zeidan, MD

Blood (2017) 130 (Supplement 1): 2114.

https://doi.org/10.1182/blood.V130.Suppl_1.2114.2114

Published: 2017

Journal Articles

Normalization of Cerebral Hemodynamics after Hematopoietic Stem Cell Transplant in Children with Sickle Cell Anemia

Monica L Hulbert, MD, Kristin P Guilliams, MD MSc, Melanie E Fields, MD, Priyesha Bijlani, Dustin K Ragan, PhD, Cihat Eldeniz, PhD, Slim Fellah, PhD, Michael M Binkley, MS, Hongyu An, DSc, Yasheng Chen, DSc, Shalini Shenoy, MD, Ginny Schulz, RN, MSN, CPNP, Alison Towerman, RN, MSN, CPNP, Robert C McKinstry, MD PhD, Joshua S Shimony, MD PhD, Jin-Moo Lee, MD PhD, Andria L Ford, MD

Blood (2017) 130 (Supplement 1): 2245.

https://doi.org/10.1182/blood.V130.Suppl_1.2245.2245

Published: 2017

Journal Articles

Evolution of Platelet Function and Bleeding in Children and Adults with Chronic Immune Trombocytopenia on Romiplostim Treatment

Anastasia Ignatova, Elena Suntsova, Pavel Zharkov, Valentina Ivanova, Irina Demina, Aleksandr Poletaev, Elena Seregina, Dmitrii Polokhov, MD, Natalia Smetanina, Alexey A Maschan, MD PhD Professor, Mikhail Maschan, PhD, Galina Novichkova, Mikhail Panteleev, PhD Dr.Sc, Prof.

Blood (2017) 130 (Supplement 1): 3636.

https://doi.org/10.1182/blood.V130.Suppl_1.3636.3636

Published: 2017

Journal Articles

Real-World Characteristics of CLL Patients Receiving Front-Line Therapy, Using the Flatiron Health Database

Boxiong Tang, MD PhD, Erika Szabo, Jifang Zhou, MD, Jerry Wu, Danielle M. Brander, MD

Blood (2017) 130 (Supplement 1): 4671.

https://doi.org/10.1182/blood.V130.Suppl_1.4671.4671

Published: 2017

Journal Articles

Elevated Pre-Therapeutic Serum Levels of Soluble Programmed Death 1 Protein (sPD-1) Identify DLBCL Patients with Adverse Prognostic Features

Julie Bondgaard Mortensen, MS, Ida Monrad Hansen, B.Sc., Michael Roost Clausen, MD, Mette Bjerre, M.Sc.PhD, Francesco d'Amore, MD PhD

Blood (2017) 130 (Supplement 1): 4148.

https://doi.org/10.1182/blood.V130.Suppl_1.4148.4148

Published: 2017

Journal Articles

Muscle Mass in Elderly Patients with DLBCL Treated with RCHOP

Iuliana Vaxman, MDBA, Agata Schlesinger, Natalia Goldberg, Meir Lahav, MD, Anat Gafter, MD, Shany Lando, Pia Raanani, MD, Liat Vidal, MDMSc

Blood (2016) 128 (22): 3044.

https://doi.org/10.1182/blood.V128.22.3044.3044

Published: 2016

Journal Articles

Ruxolitinib Remains Effective in Myelofibrosis after the Necessary Dose Reductions: Real-Life Data from a Multi-Center Observational Study

Blood (2016) 128 (22): 5476.

https://doi.org/10.1182/blood.V128.22.5476.5476

Published: 2016

Journal Articles

Microrna 221 Expression By Leukocytes Strongly Correlates with the Clinical Severity of Sickle Cell Disease

Iheanyi Okpala, FRCPath. FWACP., Ndubuisi Uwaezuoke, FMCPaed, Ifeoma Emodi, FMCPaed, Anthony Ikefuna, FMCPaed, Tagbo Oguonu, FMCPaed

Blood (2016) 128 (22): 2485.

https://doi.org/10.1182/blood.V128.22.2485.2485

Published: 2016

Journal Articles

Correlation Between Cerebral Blood Flow Velocities Measured By Magnetic Resonance and Transcranial Doppler Ultrasound in Children with Sickle Cell Anemia

Monica L. Hulbert, MD, Dustin K. Ragan, PhD, Hongyu An, PhD, Cihat Eldeniz, PhD, Geetika Khanna, MD MS, Melanie E. Fields, MD MSCI, Kristin P. Guilliams, MD MSCI, Jin-Moo Lee, MD PhD, Andria L. Ford, MD MSCI

Blood (2016) 128 (22): 2496.

https://doi.org/10.1182/blood.V128.22.2496.2496

Published: 2016

NARROW

Chromosome 1q Amplification Is Associated with a History of Prior Malignancies Among Patients Newly Diagnosed with Multiple Myeloma

A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation

Molecular Mechanisms of Primary Resistance to Azacitidine in MDS/AML Patients - Data of the Hellenic MDS Study Group

Neurodevelopmental Disorders in Pediatric Sickle Cell Disease

Interest of a New Method for Free Plasma Heme Related Species Dosages in Sickle Cell Disease and Beta Thalassemia

Characterization of Soluble Immune Checkpoint Protein PD-1, PD-L1 and PD-L2 Levels in Different Types of Lymphoid Malignancies

HMGB1 As a Novel Platelet Agonist That Acts Synergistically with ADP to Activate Platelets in Sickle Cell Disease

Impact of AML on Patients' Lives: The Value of HM-PRO Measurements

Utility of Repeat Testing in the Evaluation for Von Willebrand Disease in Pediatric Patients

Cardiorenal Syndrome in Thalassemia Patients

Cytokine Release from Stimulated PBMC after-HSCT: Results of a Post-Transplant Zinc Oral Supplementation Trial (ZENITH)

Counseling Patients (pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS) Regarding Expected Survival with Azacitidine (aza) Therapy: Are We Using Accurate Estimates?

Normalization of Cerebral Hemodynamics after Hematopoietic Stem Cell Transplant in Children with Sickle Cell Anemia

Evolution of Platelet Function and Bleeding in Children and Adults with Chronic Immune Trombocytopenia on Romiplostim Treatment

Real-World Characteristics of CLL Patients Receiving Front-Line Therapy, Using the Flatiron Health Database

Elevated Pre-Therapeutic Serum Levels of Soluble Programmed Death 1 Protein (sPD-1) Identify DLBCL Patients with Adverse Prognostic Features

Muscle Mass in Elderly Patients with DLBCL Treated with RCHOP

Ruxolitinib Remains Effective in Myelofibrosis after the Necessary Dose Reductions: Real-Life Data from a Multi-Center Observational Study

Microrna 221 Expression By Leukocytes Strongly Correlates with the Clinical Severity of Sickle Cell Disease

Correlation Between Cerebral Blood Flow Velocities Measured By Magnetic Resonance and Transcranial Doppler Ultrasound in Children with Sickle Cell Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only